
Sign up to save your podcasts
Or
Enjoy this podcast with Leonard Mazur, the co-founder, Chairman, and CEO of Citius Pharmaceuticals, a late-stage biopharma company focused on developing critical care. With over 50 years in the industry, there are many success lessons to be learned as Leonard has co-founded several companies, including Akrimax Pharmaceuticals and Genesis Pharmaceuticals, which he successfully sold to Pierre Fabre in 2003.
Disclaimer
The information contained in this website and podcast arepurely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may beconstrued as a recommendation or endorsement of any of the companies discussed.Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to update this information as changes occur.
4.3
33 ratings
Enjoy this podcast with Leonard Mazur, the co-founder, Chairman, and CEO of Citius Pharmaceuticals, a late-stage biopharma company focused on developing critical care. With over 50 years in the industry, there are many success lessons to be learned as Leonard has co-founded several companies, including Akrimax Pharmaceuticals and Genesis Pharmaceuticals, which he successfully sold to Pierre Fabre in 2003.
Disclaimer
The information contained in this website and podcast arepurely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may beconstrued as a recommendation or endorsement of any of the companies discussed.Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to update this information as changes occur.
21,927 Listeners
316 Listeners
61 Listeners
18 Listeners
22 Listeners